ad

Gayatri Bioorganics Q4 FY26 Results: Loss Rs 8.50 Cr

20 May 20261:35 pm

Gayatri Bioorganics Q4 FY26 Results: Loss Rs 8.50 Cr

Gayatri Bioorganics Q4 FY26 results were declared on May 19, 2026. Gayatri Bioorganics reported net loss of Rs 8.50 crore down 63.5% YoY from Rs 5.20 crore in Q4 FY25, on revenue of Rs 42 crore down 15.0% YoY. Gayatri Bioorganics is a Bio-organic Chemicals company listed on Indian stock exchanges. This article covers the complete Gayatri Bioorganics Q4 FY26 financial highlights, key performance factors, and FY27 outlook.

Click Here – Get Free Investment Predictions

Gayatri Bioorganics Q4 FY26 Financial Highlights

Metric Q4 FY26 Change
Net Loss Rs 8.50 crore down 63.5% YoY from Rs 5.20 crore in Q4 FY25
Revenue Rs 42 crore down 15.0% YoY

Note: Q4 FY26 net loss Rs 8.5 crore (deepening from loss Rs 5.2 crore in Q4 FY25). Revenue Rs 42 crore (-15% YoY). Mounting losses signal operational distress.

Gayatri Bioorganics Q4 FY26 Performance Analysis

the firm results reflect the January to March 2026 quarter performance. Gayatri Bioorganics operates in the Bio-organic Chemicals sector, supported by India’s GDP growth and domestic demand environment. The Q4 FY26 loss reflects near-term challenges the management is addressing.

Screen the best stocks on the Univest Screener.

Key Business Factors for the company

Revenue and Operations

it covers the seasonally important January to March 2026 quarter. India’s macro environment with GDP above 6.5% and strong domestic consumption provided a constructive backdrop for the Bio-organic Chemicals sector.

Profitability Trends

the business net loss of Rs 8.50 crore down 63.5% YoY from Rs 5.20 crore in Q4 FY25. The path to profitability and cost efficiency measures will be closely monitored in FY27.

FY27 Outlook

Following the firm results, management commentary on FY27 guidance, capex plans, and demand outlook will drive investor sentiment. The Bio-organic Chemicals sector continues to benefit from India’s structural growth story.

India Macro Environment Q4 FY26

The January to March 2026 quarter concluded India’s fiscal year 2025-26. India’s GDP growth remained above 6.5%, supported by strong government capital expenditure, rural consumption recovery, and resilient urban demand. The Reserve Bank of India maintained an accommodative monetary stance which provided liquidity support across sectors. For companies across manufacturing, services, and infrastructure, this macro backdrop translated into sustained demand conditions during the quarter. Investors evaluating the quarterly performance should contextualise individual results within this broader economic environment.

Sectoral Trends and Competitive Position

Companies reporting Q4 FY26 results operate within a dynamic competitive landscape shaped by domestic policy priorities, global supply chain realignments, and evolving consumer preferences. Government initiatives including Production Linked Incentive schemes, infrastructure pipeline expansion, and MSME support measures created tailwinds for multiple sectors during FY26. The earnings season provides an opportunity to assess how individual companies have navigated input cost pressures, workforce efficiency, and capital allocation decisions across this period.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

What is Gayatri Bioorganics Q4 FY26 PAT?

Ans. Gayatri Bioorganics Q4 FY26 PAT was net loss of Rs 8.50 crore down 63.5% YoY from Rs 5.20 crore in Q4 FY25. Results declared May 19, 2026. Verify from BSE/NSE filings before investment decisions.

What is Gayatri Bioorganics Q4 FY26 revenue?

Ans. Gayatri Bioorganics Q4 FY26 revenue was Rs 42 crore down 15.0% YoY.

When were Gayatri Bioorganics Q4 FY26 results declared?

Ans. Gayatri Bioorganics Q4 FY26 results were declared on May 19, 2026, at the board meeting approving audited Q4 and FY26 financial statements.

Is Gayatri Bioorganics a good investment after Q4 FY26?

Ans. Investment decisions require assessment of fundamentals, valuation, and risk. This article is educational only. Consult a SEBI-registered advisor before investing.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
Google for Startups Accelerator 2024
Trusted by 70 lakh+ Indians
Awarded No. 1 by Economic times